Issue 25 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

25

June 24, 2005Jun 24, 2005

Free

DOWNLOAD THE PDF

Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.

FDA orders “limited distribution” for lung cancer drug Iressa.

House approves $210 million for Dept. of Defense cancer research programs.

House Committee on Appropriations approves $28.5 billion for NIH.

House panel investigating NIH handling of tissue specimens.

Recent Issues

Volume 51 | Issue 13 - April 04, 2025

Volume 51 | Issue 12 - March 28, 2025

Volume 51 | Issue 11 - March 21, 2025

Volume 51 | Issue 10 - March 14, 2025

Volume 51 | Issue 09 - March 07, 2025

Volume 51 | Issue 08 - February 28, 2025